Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02974725
Title A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | BEL

Facility Status City State Zip Country Details
University of California San Diego San Diego California 92103 United States Details
UCSF Medical Center San Francisco California 94143 United States Details
Massachusetts General Hospital SC Boston Massachusetts 02114 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Sarah Cannon Research Institute Tennessee Oncology Nashville Tennessee 37203 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Novartis Investigative Site Westmead New South Wales 2145 Australia Details
Novartis Investigative Site Melbourne Victoria 3000 Australia Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Lyon Cedex 69373 France Details
Novartis Investigative Site Paris Cedex 10 75475 France Details
Novartis Investigative Site Villejuif Cedex 94800 France Details
Novartis Investigative Site Dresden 01307 Germany Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Frankfurt 60590 Germany Details
Novartis Investigative Site Koeln 50937 Germany Details
Novartis Investigative Site Tel Aviv 6423906 Israel Details
Novartis Investigative Site Milano MI 20133 Italy Details
Novartis Investigative Site Milano MI 20162 Italy Details
Novartis Investigative Site Rozzano MI 20089 Italy Details
Novartis Investigative Site Verona VR 37126 Italy Details
Novartis Investigative Site Napoli 80131 Italy Details
Novartis Investigative Site Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Seoul 06351 Korea, Republic of Details
Novartis Investigative Site Warszawa 02 781 Poland Details
Novartis Investigative Site Sevilla Andalucia 41013 Spain Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Barcelona Catalunya 08036 Spain Details
Novartis Investigative Site Valencia Comunidad Valenciana 46010 Spain Details
Novartis Investigative Site Pamplona Navarra 31008 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Stockholm 171 76 Sweden Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field